LISBON, March 5 (Xinhua) -- Scientists have successfully created anti-tumor immune cells in a laboratory using cellular reprogramming for the first time, opening new possibilities in the fight against ...
Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...
OpenAI is venturing into the field of longevity science with an artificial intelligence model designed to optimize the production of stem cells. This model, named GPT-4b micro, could transform ...
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver ...
CARLSBAD, CA--(Marketwire - Oct 9, 2012) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company focused ...
Cancer cells rapidly adapt to treatments, developing resistance that makes chemotherapy less effective. Researchers used an existing anti-inflammatory drug to disrupt cancer cells’ ability to adapt by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results